FEDERATED HERMES, INC. - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$42,279,706
-3.3%
1,956,488
-13.4%
0.12%
-8.6%
Q3 2022$43,717,000
-2.4%
2,258,124
+0.1%
0.13%
+4.9%
Q2 2022$44,787,000
-36.3%
2,255,124
-4.4%
0.12%
-23.3%
Q1 2022$70,358,000
+28.1%
2,358,6240.0%0.16%
+55.9%
Q4 2021$54,932,000
-25.4%
2,358,624
-0.1%
0.10%
-27.1%
Q3 2021$73,648,000
-11.3%
2,360,524
-0.0%
0.14%
-9.7%
Q2 2021$83,062,000
-0.2%
2,361,0580.0%0.16%
-3.7%
Q1 2021$83,227,000
-9.3%
2,361,058
-3.5%
0.16%
-14.4%
Q4 2020$91,787,000
+13.9%
2,447,000
+1.3%
0.19%
-0.5%
Q3 2020$80,585,000
+59.0%
2,414,900
+26.2%
0.19%
+51.2%
Q2 2020$50,680,000
+61.8%
1,913,1900.0%0.12%
+35.9%
Q1 2020$31,319,000
-14.3%
1,913,190
+33.1%
0.09%
+13.6%
Q4 2019$36,529,000
+27.1%
1,437,0000.0%0.08%
+14.1%
Q3 2019$28,740,000
-38.0%
1,437,0000.0%0.07%
-36.6%
Q2 2019$46,329,000
+99.9%
1,437,000
+99.7%
0.11%
+96.5%
Q1 2019$23,178,000
+61.2%
719,595
+22.8%
0.06%
+46.2%
Q4 2018$14,378,000
-25.6%
586,146
-0.0%
0.04%
-13.3%
Q3 2018$19,321,000
-7.1%
586,207
+0.0%
0.04%
-26.2%
Q2 2018$20,808,000
+106.1%
586,146
+89.1%
0.06%
+110.3%
Q1 2018$10,094,000309,9250.03%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders